<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11620000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q9Y5K5</UniProt_ID>
  <Seq_Length>329</Seq_Length>
  <Molecule_Weight>37607</Molecule_Weight>
  <KEGG_ID>hsa:51377</KEGG_ID>
  <Orthology_ID>K05610</Orthology_ID>
  <EBI_ID>EBI-1051183</EBI_ID>
  <Function_Summary>Protease that specifically cleaves 'Lys-48'-linked polyubiquitin chains. Deubiquitinating enzyme associated with the 19S regulatory subunit of the 26S proteasome. Putative regulatory component of the INO80 complex; however is inactive in the INO80 complex and is activated by a transient interaction of the INO80 complex with the proteasome via ADRM1.</Function_Summary>
  <Catalytic_Mechanism>Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).</Catalytic_Mechanism>
  <Pfam_ID>PF01088:Peptidase_C12</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Ubiquitin thioesterase L5</Alias>
      <Alias>UCH-L5</Alias>
      <Alias>Ubiquitin C-terminal hydrolase UCH37</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a proteasome, a large multisubunit protein complex that catalyzes protein degradation.</Detail>
      <Keyword>Proteasome binding</Keyword>
      <Ontology_ID>GO:0070628</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the removal of terminal peptide residues that are substituted, cyclized or linked by isopeptide bonds (peptide linkages other than those of alpha-carboxyl to alpha-amino groups).</Detail>
      <Keyword>Omega peptidase activity</Keyword>
      <Ontology_ID>GO:0008242</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Stops, prevents or reduces the activity of an endopeptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.</Detail>
      <Keyword>Endopeptidase inhibitor activity</Keyword>
      <Ontology_ID>GO:0004866</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various forms of polymeric ubiquitin sequences.</Detail>
      <Keyword>Ubiquitin-specific protease activity</Keyword>
      <Ontology_ID>GO:0004843</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006355</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a transforming growth factor beta receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Transforming growth factor beta receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007179</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.</Detail>
      <Keyword>Negative regulation of transforming growth factor beta receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0030512</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.</Detail>
      <Keyword>Ubiquitin-dependent protein catabolic process</Keyword>
      <Ontology_ID>GO:0006511</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Intrachromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.</Detail>
      <Keyword>DNA recombination</Keyword>
      <Ontology_ID>GO:0006310</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the lateral ventricles over time, from the formation to the mature structure. The two lateral ventricles are a cavity in each of the cerebral hemispheres derived from the cavity of the embryonic neural tube. They are separated from each other by the septum pellucidum, and each communicates with the third ventricle by the foramen of Monro, through which also the choroid plexuses of the lateral ventricles become continuous with that of the third ventricle.</Detail>
      <Keyword>Lateral ventricle development</Keyword>
      <Ontology_ID>GO:0021670</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.</Detail>
      <Keyword>DNA repair</Keyword>
      <Ontology_ID>GO:0006281</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.</Detail>
      <Keyword>Regulation of proteasomal protein catabolic process</Keyword>
      <Ontology_ID>GO:0061136</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.</Detail>
      <Keyword>Negative regulation of endopeptidase activity</Keyword>
      <Ontology_ID>GO:0010951</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The removal of one or more ubiquitin groups from a protein.</Detail>
      <Keyword>Protein deubiquitination</Keyword>
      <Ontology_ID>GO:0016579</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of the forebrain are generated and organized. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).</Detail>
      <Keyword>Forebrain morphogenesis</Keyword>
      <Ontology_ID>GO:0048853</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).</Detail>
      <Keyword>Midbrain development</Keyword>
      <Ontology_ID>GO:0030901</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.</Detail>
      <Keyword>Response to DNA damage stimulus</Keyword>
      <Ontology_ID>GO:0006974</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>47</Position>
      <PTM_Type>N6-succinyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>289</Position>
      <PTM_Type>N6-succinyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>158</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNCTHQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAEEEPMDTDQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELLKTLAEHQQLIPLVEKAKEKQNAKKAQETK</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Ino80 complex</CellLocal>
      <Ontology_ID>GO:0031011</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Proteasome complex</CellLocal>
      <Ontology_ID>GO:0000502</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>UCHL5</Gene_Name>
    <Gene_Alias>UCH37</Gene_Alias>
    <Gene_ID>51377</Gene_ID>
    <Genbank_ACCN>NM_001199261</Genbank_ACCN>
    <Protein_ACCN>NP_001186190</Protein_ACCN>
    <HGNC_ID>19678</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/51377</Gene_URL>
    <UCSC_ID>uc001gsq.3</UCSC_ID>
    <EMBL_ID>ENSG00000116750</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P60900</Uniprot_ID>
      <Gene_Name>PSMA6</Gene_Name>
      <EBI_ID>EBI-357793</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-357793</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P55036</Uniprot_ID>
      <Gene_Name>PSMD4</Gene_Name>
      <EBI_ID>EBI-359318</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-359318</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q6P4R8</Uniprot_ID>
      <Gene_Name>NFRKB</Gene_Name>
      <EBI_ID>EBI-2511210</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-2511210</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13200</Uniprot_ID>
      <Gene_Name>PSMD2</Gene_Name>
      <EBI_ID>EBI-357648</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-357648</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9H981</Uniprot_ID>
      <Gene_Name>ACTR8</Gene_Name>
      <EBI_ID>EBI-769597</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-769597</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q16186</Uniprot_ID>
      <Gene_Name>ADRM1</Gene_Name>
      <EBI_ID>EBI-954387</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-954387</PPI_EBI_URL>
      <Experiment_Number>17</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P0C1Z6</Uniprot_ID>
      <Gene_Name>TFPT</Gene_Name>
      <EBI_ID>EBI-1245626</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-1245626</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8NBZ0</Uniprot_ID>
      <Gene_Name>INO80E</Gene_Name>
      <EBI_ID>EBI-769401</EBI_ID>
      <PPI_EBI_URL>EBI-1051183,EBI-769401</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Cannabis Dependence</Disease_Name>
      <Disease_Detail>Cannabis Dependence</Disease_Detail>
      <Disease_DB>CNN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cannabis_dependence?search=UCHL5#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme</PDB_Title>
      <PDB_ID>3RIS</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RIS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme.</PubMed_Title>
      <Author>Maiti, T.K., et al.</Author>
      <Journal>Febs J.(2011)278:4917-4926</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21995438?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme</PDB_Title>
      <PDB_ID>3RII</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3RII</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme.</PubMed_Title>
      <Author>Maiti, T.K., et al.</Author>
      <Journal>Febs J.(2011)278:4917-4926</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21995438?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Catalytic domain of UCH37</PDB_Title>
      <PDB_ID>3A7S</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3A7S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the UCH domain of UCH-L5 with 6 residues deleted</PDB_Title>
      <PDB_ID>3TB3</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3TB3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains.</PubMed_Title>
      <Author>Zhou, Z.R., et al.</Author>
      <Journal>Biochem.J.(2012)441:143-149</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21851340?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Uch37</PDB_Title>
      <PDB_ID>3IHR</PDB_ID>
      <Resolution>2.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IHR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural characterization of human Uch37.</PubMed_Title>
    </PDB>
  </PDB_List>
  <Fold>
    <CATH_Class>Class 3: Mixed Alpha-Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/3a7s</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.19.12</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/19/12.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>